The markets extended its losses during the midday with the Dow falling 58 points to 16,386 as December hiring tumbled. Nasdaq lost 6 points to 4149.
On the upside
Francesca's Holdings (Nasdaq: FRAN) narrowed its fourth quarter outlook to the high end of its previous guidance.
Immunomedics (Nasdaq: IMMU) initiated a Phase III clinical trial of its pancreatic cancer treatment clivatuzumab tetraxetan.
Abercrombie & Fitch (NYSE: ANF) lifted its full year earnings outlook due to better than expected sales.
On the downside
YRC Worldwide's (Nasdaq: YRCW) Teamsters union voted against a contract extension that was necessary for the transportation services company to refinance its debt and avoid bankruptcy.
Natural Resources Partners (NYSE: NRP) affirmed its previous 2013 full year forecast which fell far short of analyst expectations and forecast 2014 results below estimates.
Pacific Sunwear (Nasdaq: PSUN) forecast a greater than expected loss for the fourth quarter on lower revenue.
In the broad market, advancing issues outpaced decliners by a margin of 5 to 3 on the NYSE while decliners edged out advancers by nearly 7 to 5 on Nasdaq. The broader S&P 500 lost 5 points to 1832. Bitcoin slipped $22.02 or 2.41% to $913.10.
